Global Birth Defects Market, By Type (Structural, Functional/Developmental, Others), Extremities (Lower Extremities, Upper Extremities), Treatment (Diagnosis, Surgical, Medication) – Industry Trends and Forecast to 2029.
Market Analysis and Size
Birth defects are highly common in highly populated regions. Each year, more than 40,000 babies are born with birth defects. Conjoined twins, heart defects, cleft lip and palate and spina bifida are some of the most common birth defects. 2%-3% of infants develop more than one defects and the number has increased to 5% by age one in the recent years. However, it must be noted that many birth defects are not discovered during the birth but are discovered in the later stages of life.
- Data Bridge Market Research analyses that the birth defects market is expected to undergo a CAGR of 4.70% during the forecast period. “Diagnoses” accounts for the largest treatment segment in the birth defects market owing to the increasing prevalence of birth defects in the underdeveloped and backward regions globally.
Birth defects are the changes in the body that can affect any other part of the body. They are often inherited medical conditions or genetic defects. Birth defects can be referred to as the problems that develop in the babies when in mother’s body. In other words, birth defects are something physically, structurally, chemically or internally abnormal in the babies.
Birth Defects Market Dynamics
Leading an abnormal and unhealthy lifestyle makes the body a host to a wide range of infections and diseases. These infections directly or indirectly affect the functioning of many vital organs which in turn hinders the general bodily processes. Excessive consumption of alcohol and tobacco products can damage the sperm production and can cause bodily defects. This is one of the biggest factors of birth defects.
Rising prevalence of disorders
Growing incidence rate of genetic disorders such as obesity and diabetes is another important factor fostering growth in the demand for birth defect treatments from all around the world. A single gene can lead to birth defects in babies such as heart defects.
Government investments on healthcare infrastructure
The increase in the funding by the federal government is set to drive the demand for birth defects treatment. Moreover, growth and expansion of healthcare industry being driven by both public and private players especially in the developing economies will create lucrative market growth opportunities.
Additionally, surge in the personal disposable income level, increasing investment in research activities for the development of advanced technology, increasing the number of preterm births and growing technological advancements, positively affect the birth defects market.
Furthermore, increasing focus of major manufacturers on integration and installation of advanced and modern technologies will extend profitable opportunities for the market players in the forecast period of 2022 to 2029. Additionally, increasing number of diagnostic centres and hospitals and rising technological advancements in infant and maternal care products will further expand the birth defects market's growth rate in the future.
On the other hand, high cost associated with the diagnosis, surgeries and treatment, shortage of skilled medical professionals, limited awareness in rural areas and high expenditure required for research and developmental activities are expected to obstruct market growth. Also, dearth of required infrastructural facilities in the underdeveloped and backward regions is projected to challenge the birth defects market in the forecast period of 2022-2029.
This birth defects market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the birth defects market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Birth Defects Market
According to an article published in the BMJ Journal, there was a dramatic decline in the number of intensive new-born care all around the world. Though, there was a rise in the pregnancy rate and rate of birth defects, the birth defects treatment facilities saw a decline in their revenue owing to the increased focus of the healthcare institutions towards treating COVID-19 infected patients. Dearth of required infrastructural and institutional resources was responsible for making revenue for birth defects treatment market.
- Abdul Latif Jameel General Trading Co. collaborated with Melody International in November 2021 for the distribution of Melody’s innovative iCTG remote fetal monitor.
Global Birth Defects Market Scope
The birth defects market is segmented on the basis of type, extremities and treatment. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Based on type, the birth defects market is segmented into structural, functional/ developmental and others. Structural have been further segmented into cleft lip or cleft palate, heart defects, abnormal limbs and neural tube defects. Functional/developmental have been further segmented into nervous system or brain problems, sensory problems, metabolic disorders and degenerative disorders. Other have been further segmented into deletion syndrome, albinism, ocular, albinism, oculocutaneous, anencephaly, arnold-chiari malformation, charge syndrome, congenital adrenal hyperplasia, congenital diaphragmatic hernia, congenital hydrocephalus, craniosynostosis, dandy walker malformation, ehlers danlos syndrome, epidermolysis bullosa, gorham's disease, hashimoto's syndrome, hydrops fetalis, hypotonia, klippel-feil syndrome, muscular dystrophy, osteogenesis imperfect, progeria, smith lemli opitz syndrome, spinal muscular atrophy, tuberous sclerosis, turner syndrome and x-linked lymphoproliferative syndrome.
- Lower Extremities
- Upper Extremities
Birth defects market segmented based on the extremities into lower extremities and upper extremities, lower extremities have been further segmented into thigh, knee, leg, ankle, foot, and toes. Upper extremities have been further segmented into heart, brain, arm, shoulder and others.
Based on treatment, the birth defects market is segmented into diagnosis, surgical and medication.
Birth Defects Market Regional Analysis/Insights
The birth defects market is analysed and market size insights and trends are provided by country, type, extremities and treatment as referenced above.
The countries covered in the birth defects market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the birth defects market because of the strong base of healthcare facilities, high prevalence of diabetes and obesity in the region and the presence of major key players within the region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increase in government initiatives to promote awareness, rise in medical tourism, unhealthy lifestyle of individuals, rising prevalence of genetic disorders and the growing demand for quality healthcare in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The birth defects market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for birth defects market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the birth defects market. The data is available for historic period 2010-2020.
Competitive Landscape and Birth Defects Market Share Analysis
The birth defects market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to birth defects market.
Some of the major players operating in the birth defects market are Advanced Vision Therapy., AlphaVax, Altogen Biosystems, American Gene Technologies Inc., Applied Tissue Technologies LLC, ARTHROGEN, Asklepios BioPharmaceutical, Inc., Medtronic, Abbott, Boston Scientific Corporation, Edwards Lifesciences Corporation., Johnson & Johnson Services, Inc., Getinge AB, Terumo Cardiovascular Systems Corporation, W. L. Gore & Associates, Inc., Lepu Medical Technology(Beijing)Co.,Ltd., Allscripts Healthcare, LLC, Carestream Health, Agfa-Gevaert Group and BD among others.